Expanded question: What are the evidence-based talk-therapy intervention options for clinical depression?

Answered on June 13, 2024
Evidence-based talk-therapy interventions for clinical depression include several well-validated approaches. The most extensively studied and recommended therapies are Cognitive Behavioral Therapy (CBT) and Interpersonal Psychotherapy (IPT). Both have demonstrated efficacy in both the acute and maintenance phases of Major Depressive Disorder (MDD).[1-2]
CBT focuses on identifying and modifying negative thought patterns and behaviors associated with depression. It includes techniques such as cognitive restructuring and behavioral activation. CBT can be delivered in various formats, including individual, group, telephone, and guided self-help, all of which have shown similar effectiveness.[3]
IPT addresses interpersonal issues that may contribute to depressive symptoms, such as role transitions, grief, and interpersonal disputes. It is particularly effective in improving social functioning and reducing depressive symptoms.[1-2]
Other therapies with significant evidence include Behavioral Activation, which focuses on increasing engagement in positively reinforcing activities, and Problem-Solving Therapy (PST), which helps patients develop coping strategies to manage life stressors.[1-2]
Short-term Psychodynamic Psychotherapy (STPP) has also been recommended as an initial treatment option for uncomplicated MDD, based on recent noninferiority trials comparing it to CBT.[2]
Emerging therapies such as Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Cognitive Therapy (MBCT) have shown promise, particularly in preventing relapse, but require further research to establish their efficacy as acute treatments.[1][4]
The U.S. Department of Veterans Affairs and U.S. Department of Defense recommend these therapies as initial treatment options, emphasizing that no single therapy has been found superior to others, and the choice should consider patient preferences and provider expertise.[2]

1.
Leading Journal

Cognitive-Behavioural Therapy (CBT) and Interpersonal Therapy (IPT) continue to have the most evidence for efficacy, both in acute and maintenance phases of MDD, and have been studied in combination with antidepressants. CBT is well studied in conjunction with computer-delivered methods and bibliotherapy. Behavioural Activation and Cognitive-Behavioural Analysis System of Psychotherapy have significant evidence, but need replication. Newer psychotherapies including Acceptance and Commitment Therapy, Motivational Interviewing, and Mindfulness-Based Cognitive Therapy do not yet have significant evidence as acute treatments; nor does psychodynamic therapy.
Although many forms of psychotherapy have been studied, relatively few types have been evaluated for MDD in randomized controlled trials. Evidence about the combination of different types of psychotherapy and antidepressant medication is also limited despite widespread use of these therapies concomitantly.

2.
The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.

McQuaid JR, Buelt A, Capaldi V, et al.

Annals of Internal Medicine. 2022;175(10):1440-1451. doi:10.7326/M22-1603.

Leading Journal

Many factors influence the relative effectiveness of synchronous telemedicine, including patient comfort and familiarity with health care technologies. As a result, even though the work group found great potential for synchronous telemedicine, the evidence base was insufficient to make a recommendation. The work group expects that ongoing trials will provide more information on this in the future.
In the prior guideline, 6 forms of psychotherapy were recommended for initial treatment of depression, including (in alphabetical order) acceptance and commitment therapy, behavioral therapy/behavioral activation, CBT, interpersonal psychotherapy, mindfulness-based cognitive therapy, and problem-solving therapy. The evidence review supported continuing to recommend these therapies. In addition, the updated guideline includes a recommendation for STPP as an initial treatment option for uncomplicated MDD (Recommendation 7; Table). This update was based on 2 new randomized controlled noninferiority trials comparing STPP and CBT (18, 19). Of the selected psychotherapies, the evidence did not suggest that any of them are more effective than any other in reducing depressive symptoms or achieving remission. There were also no specific CBT packages that offered notable advantages over traditional CBT, such as metacognitive therapy or cognitive evolutionary therapy (20, 21). Group and individual delivery methods seemed to provide similar outcomes. Factors such as patient preferences, past experience with treatment, and provider training should be considered when selecting specific approaches.

3.
Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-Analysis.

Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA.

JAMA Psychiatry. 2019;76(7):700-707. doi:10.1001/jamapsychiatry.2019.0268.

Leading Journal

Importance: Cognitive behavior therapy (CBT) has been shown to be effective in the treatment of acute depression. However, whether CBT can be effectively delivered in individual, group, telephone-administered, guided self-help, and unguided self-help formats remains unclear. Objective: To examine the most effective delivery format for CBT via a network meta-analysis. Data Sources: A database updated yearly from PubMed, PsycINFO, Embase, and the Cochrane Library. Literature search dates encompassed January 1, 1966, to January 1, 2018. Study Selection: Randomized clinical trials of CBT for adult depression. The 5 treatment formats were compared with each other and the control conditions (waiting list, care as usual, and pill placebo). Data Extraction and Synthesis: PRISMA guidelines were used when extracting data and assessing data quality. Data were pooled using a random-effects model. Pairwise and network meta-analyses were conducted. Main Outcomes and Measures: Severity of depression and acceptability of the treatment formats. Results: A total of 155 trials with 15 191 participants compared 5 CBT delivery formats with 2 control conditions. In half of the studies (78 [50.3%]), patients met the criteria for a depressive disorder; in the other half (77 [49.7%]), participants scored above the cutoff point on a self-report measure. The effectiveness of individual, group, telephone, and guided self-help CBT did not differ statistically significantly from each other. These formats were statistically significantly more effective than the waiting list (standardized mean differences [SMDs], 0.87-1.02) and care as usual (SMDs, 0.47-0.72) control conditions as well as the unguided self-help CBT (SMDs, 0.34-0.59). In terms of acceptability (dropout for any reason), individual (relative risk [RR] = 1.44; 95% CI, 1.09-1.89) and group (RR = 1.38; 95% CI, 1.06-1.80) CBT were significantly better than guided self-help. Guided self-help was also less acceptable than being on a waiting list (RR = 0.63; 95% CI, 0.52-0.75) and care as usual (RR = 0.72; 95% CI, 0.57-0.90). Sensitivity analyses supported the overall findings. Conclusions and Relevance: For acute symptoms of depression, group, telephone, and guided self-help treatment formats appeared to be effective interventions, which may be considered as alternatives to individual CBT; although there were few indications of significant differences in efficacy between treatments with human support, guided self-help CBT may be less acceptable for patients than individual, group, or telephone formats.

4.
Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy for Depressive Disorders.

Lee SH, Cho SJ.

Advances in Experimental Medicine and Biology. 2021;1305:295-310. doi:10.1007/978-981-33-6044-0_16.

Recently, the importance of cognitive behavioral therapy (CBT) in the treatment of depression is gradually emerging. Particularly, mindfulness meditation has various approaches related to dialectical behavioral therapy (DBT), acceptance and commitment therapy (ACT), mindfulness-based stress reduction (MBSR), and mindfulness-based cognitive therapy (MBCT), and evidence has been provided that they alleviate depressive symptoms. In particular, as MBCT increases the level of evidence in the treatment of repetitive depressive disorders, guidelines are being recommended to prevent recurrence. Mindfulness may also contribute to improving the patient's symptoms as well as improving the therapeutic relationship with the therapist. For both mindful patients and therapists, positive awareness of internal experiences can be a good way to enrich the mind and overcome depressive disorders.